Bionik Laboratories Corp. Stock
Stocks
BNKL
US09074A2087
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
09:51:08 2025-03-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -99.90% |
|
-.--% | +9,900.00% |
| 23-06-27 | Bionik Laboratories Corp. Announces Executive Changes | CI |
| 23-06-21 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| Market Cap | 12 10.55 9.98 9.05 17 1.15K 17.1 119.49 46.15 587.79 45.05 44.08 1.89K | P/E 2022 |
-0.21x | P/E 2023 | -0.56x |
|---|---|---|---|---|---|
| Enterprise Value | 1.98M 1.75M 1.65M 1.5M 2.81M 191M 2.83M 19.77M 7.63M 97.23M 7.45M 7.29M 312M | EV / Sales 2022 |
0.17x | EV / Sales 2023 | 2.65x |
| Free-Float |
100% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -99.90% | ||
| 6 months | +9,900.00% | ||
| Current year | +9,900.00% |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0.26 | |
| 5 years | 0 | 2.9 | |
| 10 years | 0 | 222.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Russo
CEO | Chief Executive Officer | 46 | 2021-07-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Michal Prywata
BRD | Director/Board Member | 35 | 2019-03-17 |
| Director/Board Member | 70 | 2017-08-31 | |
Richard Russo
BRD | Director/Board Member | 46 | 2022-10-12 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/13/23 | Conversion | Chairman | 186,112 | 1.4416% | ||
| 6/13/23 | Conversion | Director | 3,102,878 | 24.0337% | ||
| 6/9/23 | Buy | Director | 180,555 | 1.3985% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -99.90% | -.--% | -.--% | -99.96% | 1.26K | ||
| +0.53% | +3.01% | +46.17% | +34.91% | 251B | ||
| +1.27% | +5.32% | +22.99% | -8.03% | 160B | ||
| +2.37% | +3.27% | -5.97% | +40.06% | 147B | ||
| +0.43% | +0.89% | -55.07% | -17.35% | 63.93B | ||
| +0.63% | -1.71% | +13.88% | +24.11% | 50.05B | ||
| +1.40% | +8.19% | +42.00% | +56.44% | 49.4B | ||
| +2.33% | +1.84% | -14.54% | -19.90% | 48.94B | ||
| +2.17% | +4.49% | +51.84% | +60.86% | 43.52B | ||
| +0.70% | +13.85% | +196.54% | +105.44% | 41.06B | ||
| Average | -9.09% | +3.82% | +29.78% | +17.66% | 85.41B | |
| Weighted average by Cap. | +0.87% | +4.07% | +27.22% | +26.03% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.27M 1.12M 1.06M 961K 1.8M 122M 1.81M 12.68M 4.9M 62.39M 4.78M 4.68M 200M | 1.81M 1.59M 1.5M 1.36M 2.56M 173M 2.57M 17.98M 6.94M 88.42M 6.78M 6.63M 284M |
| Net income | -10.41M -9.15M -8.66M -7.85M -14.74M -999M -14.83M -104M -40.03M -510M -39.08M -38.23M -1.64B | -4.95M -4.35M -4.11M -3.73M -7.01M -475M -7.05M -49.25M -19.02M -242M -18.57M -18.17M -779M |
| Net Debt | -1.99M -1.75M -1.66M -1.5M -2.82M -191M -2.84M -19.83M -7.66M -97.54M -7.48M -7.31M -313M | 1.98M 1.75M 1.65M 1.5M 2.81M 191M 2.83M 19.77M 7.63M 97.23M 7.45M 7.29M 312M |
Employees
-
- Stock Market
- Stocks
- BNKL Stock
Select your edition
All financial news and data tailored to specific country editions
















